{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:41:38Z","timestamp":1772232098631,"version":"3.50.1"},"reference-count":10,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"DOI":"10.15420\/ecr.2020.20","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T11:00:53Z","timestamp":1595156453000},"source":"Crossref","is-referenced-by-count":1,"title":["Smoking and Angiotensin-converting Enzyme Inhibitor\/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019"],"prefix":"10.15420","volume":"15","author":[{"given":"Marco","family":"Rossato","sequence":"first","affiliation":[{"name":"Clinica Medica 3, Department of Medicine \u2013 DIMED, University Hospital of Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Di Vincenzo","sequence":"additional","affiliation":[{"name":"Clinica Medica 3, Department of Medicine \u2013 DIMED, University Hospital of Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Komiyama M, Hasegawa K. Smoking cessation as a public health measure to limit the coronavirus disease 2019 pandemic. Eur Cardiol 2020;15:e16. https:\/\/doi.org\/10.15420\/ecr.2020.11; PMID: 32373189.","DOI":"10.15420\/ecr.2020.11"},{"key":"ref1","unstructured":"WHO. Tobacco. Key facts. 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco (accessed 27 May 2020)."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271\u201380.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052; PMID: 32142651.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med 2020;75:107\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2020.03.014; PMID: 32192856.","DOI":"10.1016\/j.ejim.2020.03.014"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Miyara M, Tubach F, Pourcher V, et al. Low rate of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios 2020. https:\/\/doi.org\/10.32388\/WPP19W.4; preprint.","DOI":"10.32388\/wpp19w"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Mancia G, Rea F, Ludergnani M, et al. Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19. N Engl J Med 2020;382:2431\u201340. https:\/\/doi.org\/10.1056\/NEJMoa2006923; PMID:\u00a032356627.","DOI":"10.1056\/nejmoa2006923"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Rossato M, Russo L, Mazzocut S, et al. Current smoking is not associated with COVID-19. Eur Respir J 2020;55:2001290. https:\/\/doi.org\/10.1183\/13993003.01290-2020; PMID:\u00a032350106.","DOI":"10.1183\/13993003.01290-2020"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Oakes JM, Fuchs RM, Gardner JD, et al. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2018;315:R895\u2013906. https:\/\/doi.org\/10.1152\/ajpregu.00099.2018. PMID: 30088946.","DOI":"10.1152\/ajpregu.00099.2018"},{"key":"ref8","unstructured":"European Society of Cardiology. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. 2020. https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (accessed 27 May 2020)."},{"key":"ref9","unstructured":"American College of Cardiology. HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. 2020. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-RAAS-antagonists-in-COVID-19 (accessed 27 May 2020)."}],"container-title":["European Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2020.20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:16:42Z","timestamp":1613819802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2020.20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":10,"URL":"https:\/\/doi.org\/10.15420\/ecr.2020.20","relation":{"is-comment-on":[{"id-type":"doi","id":"10.15420\/ecr.2020.11","asserted-by":"subject"}],"has-reply":[{"id-type":"doi","id":"10.15420\/ecr.2020.25","asserted-by":"object"}]},"ISSN":["1758-3764","1758-3756"],"issn-type":[{"value":"1758-3764","type":"electronic"},{"value":"1758-3756","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"e54"}}